Welcome

World Pharma News is an ambitious online news service dedicated to the world pharmaceutical industry. Our main goal is to keep our readers informed about the latest worldwide pharmaceutical news, realizations and achievements.

Register now to be in touch with our last developments and achievements or Subscribe to World Pharma News alerts by Email (a free service delivered by FeedBurner).

Non progredi est regredi.

World Pharma News .net Explore the first worldwide Web 2.0 pharmaceutical news portal and 'Vote', 'Comment' or 'Submit' pharmaceutical news articles or other pharmaceutical web resources!
For further information, please visit http://www.worldpharmanews.net
Google Groups
Get all news digests delivered to your inbox, subscribe to World Pharma News Google Group.
Email:

Pharmaceutical Companies

[ A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Z ]

Pharmaceutical RSS News

Start your day with worldwide pharmaceutical RSS news
[ Amgen | AstraZeneca | Boehringer Ingelheim | Bristol-Myers Squibb | GlaxoSmithKline | Janssen-Cilag | Johnson & Johnson | Novartis | Novo Nordisk | Pfizer | Roche | Shire | Takeda ]
European Commission European Commission - Pharmaceuticals
FDA US Food and Drug Administration

Sponsored Ads

Advertisement
Google

Sponsored Ads

 

World Pharma News .net / Published News

Our RSS News Channels

Sponsored Ads

Research & Development News Channel
Screen and Stage Legend Phylicia Rashad Launches a Campaign Close to Her Heart
Thursday, 13 September 2007
One of America's best-loved TV moms, The Cosby Show's Phylicia Rashad is taking on a new leading role in raising awareness of Peripheral Artery Disease (P.A.D.), a condition that affects about 8 million Americans, and puts them at more than double the risk of heart attack or stroke and more than four times the risk of dying from heart disease including heart attack and stroke. However, according to the P.A.D. Coalition, most people are unaware of P.A.D. and the risks associated with it.
Read more...
 
European Commission Launches Consultation on Pharmaceuticals
Monday, 10 September 2007
European CommissionThe European Commission has launched a consultation on the future of pharmaceuticals for human use in Europe, as a part of its programme to improve the regulatory, non-regulatory and research, technology and development framework for pharmaceuticals. In an explanatory note, the Commission highlights three major challenges impacting the pharmaceutical sector in Europe: the globalisation of the sector; the smooth functioning of the internal market; and advances in science and technology.
Read more...
 
EU committee recommends omega-3 supplements during pregnancy
Friday, 07 September 2007
Pregnant women should take a daily supplement of omega-3 acids, an EU supported consensus committee has recommended. The supplement would increase the likelihood of a healthy birth and boost child development. The committee, composed of more than 50 nutritional experts from the EU-funded projects Perinatal Lipid Nutrition Group (PeriLip) and Early Nutrition Programming (EARNEST), said it had found that women who included DHA in their diet had healthier pregnancies, that their children had healthier birth weights and that they were less likely to give birth prematurely.
Read more...
 
International Study Finds New Drugs Combination to Cut Deaths from Diabetes
Tuesday, 04 September 2007
The largest-ever study of treatments for diabetes has shown that a combination of two blood pressure-lowering drugs reduces the risk of death, heart attack and kidney disease in diabetes sufferers. The "Action in diabetes and vascular disease" (ADVANCE) project involves 20 countries from around the world, 12 of them from the EU. The results were presented at the European Society of Cardiology Congress in Vienna, Austria, on 3 September.
Read more...
 
The Future of Pharmaceuticals for Human Use in Europe
Friday, 31 August 2007
European CommissionThe European pharmaceutical industry makes an irreplaceable contribution to Europe's wellbeing through the availability of medicines, economic growth and employment. The pharmaceutical sector has been and remains a key strategic sector for Europe.
Read more...
 
Study Trends Online Professional Activities and Reveals Specialty-specific Marketing Opportunities
Thursday, 30 August 2007
Manhattan ResearchManhattan Research, a healthcare market research services firm, announced the leading pharmaceutical product website destinations for physicians from its new physician research study, "ePharma Physician® v7.0: The Future of Professional eMarketing.". Manhattan Research recently hosted a webcast discussing highlights of the ePharma Physician® v7.0 research.
Read more...
 
Putnam Associates Study Finds Insurers Want More Prescription Drug Use
Saturday, 07 July 2007
Putnam Associates released today the results of an intensive study of U.S. health insurance plans' perceptions of branded prescription drug use in the U.S. The study revealed that plans believe greater pharmacoeconomic value can be unlocked by increasing patient use within certain drug categories.
Read more...
 
Patients and Healthcare Providers to Experience Significant Benefits from the Use of the Internet
Thursday, 05 July 2007
The growth of Internet applications in healthcare has been rapid. A growing number of patients are becoming increasingly involved in the healthcare service they receive. These 'power patients' possess characteristics that distinguish them from traditional patients and are an important factor in driving the use of the Internet in healthcare.
Read more...
 
Merck's Investigational Integrase Inhibitor for HIV
Wednesday, 27 June 2007
Merck & Co., Inc.Merck & Co., Inc. announced today that the U.S. Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for ISENTRESS™ (raltegravir, previously known as MK-0518). Data in the NDA support the proposed use of ISENTRESS in combination with other antiretroviral agents for the treatment of HIV-1 infection in treatment-experienced patients with evidence of HIV-1 replication despite ongoing antiretroviral therapy (ART).
Read more...
 
UK Body Recommends Pfizer's Champix (varenicline) for Smokers
Wednesday, 30 May 2007
PfizerPfizer Inc announced today that the National Institute for Health and Clinical Excellence (NICE) in the United Kingdom has recommended Champix (varenicline) for use on the National Health Service for adult smokers who have expressed a desire to quit. This gives smokers across England, Wales and Northern Ireland access to another important treatment option to help them quit smoking.
Read more...
 
<< Start < Prev 11 Next > End >>

Results 101 - 110 of 110
[ Back ]
Submit to World Pharma News .net

Most Read - Research & Development

Sponsored Ads